Review Article
Volume 10 Issue 3 - 2021
An Overview of Suicide Study
Da-Yong Lu1*, Hong-Ying Wu2, Shan Cao3 and Jin-Yu Che1
1School of Life Science, Shanghai University, Shanghai, China
2College of Science, Shanghai University, Shanghai, China
3Kyoto University of Art and Design, Kyoto, Japan
*Corresponding Author: Da-Yong Lu, School of Life Science, Shanghai University, Shanghai, China.
Received: April 15, 2020; Published: February 26, 2021


Human suicide is a dangerous clinical event causing 2% of human mortality. Due to this dangerous and complex character, human suicide study is in a high demand now. A great sum of money and abundant human resources are allocated for the development of human suicide prediction, preventions and useful medical intervention. In order to promote this noteworthy subject, biomedical scientific study is indispensable. Historically, suicide knowledge was greatly based on mental illness study. Suicide/mood disorder diagnostics and treatments have been lasting over 2000 years (Hippocrates in 460 - 377, BC). From a long history of suicide/mood disorder association, the terminology aspects have been evolving greatly. Yet, diagnostic and therapeutic study is almost fruitless in mortality reduction. No 100% effective therapeutic means has been developed. To change this scenario, past history and literatures need to be carefully reviewed.


Keywords: Suicide; Psychiatric Disease; Mood Disorder; Terminology; Diagnostics; Mental Illness; Suicide Mortality


    1. Bondy B., et al. “Genetics of suicide”. Molecular Psychiatry 11 (2006): 336-351.
    2. Lu DY. “Suicide Risks and Treatments, New Ideas and Future Perspectives”. Edition Da-Yong Lu, Nova Science Publishers (2017).
    3. Serafini G., et al. “Suicidal ideation: a comprehensive overview”. Suicidal Ideation: Predictors, Prevalence and Prevention. Ed. Bradley Weaver. Nova Science Publishing. US 1 (2015): 1-42.
    4. Lu DY., et al. “Introduction for suicide study”. Journal Metabolic Syndrome 2 (2017): 227.
    5. Lu DY., et al. “The efficacies and toxicities of antidepressant drugs in clinics, building the relationship between Chemo-Genetics and Socio-Environments”. Central Nervous System Agents in Medicinal Chemistry 1 (2016): 12-18.
    6. Marreros A. “Mood disorders: epidemiology and natural history”. Psychiatry 2 (2008): 52-55.
    7. Lu DY., et al. “Human suicide study, is there an association between suicide and mental illness”. Metabolomics3 (2016): 186.
    8. Davison K. “Historical aspects of mood disorders”. Psychiatry4 (2006): 115-118.
    9. Lu DY., et al. “Historical analysis of suicide/mental disorder and current diagnostics in clinics”. Suicide Risks and Treatments, New Ideas and Future Perspectives. Edition Da-Yong Lu, Chapter (2017): 1-12.
    10. Lu DY., et al. “Genetics and bioinformatics study of antidepressant drugs, recent advancements and future trends. Suicidal Ideation: Predictors, Prevalence and Prevention”. Edition. Bradley Weaver. Nova Science Publishing. US 3 (2015): 57-71.
    11. While D., et al. “Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study”. Lancet 379 (2012): 1005-1012.
    12. Frangou S. “Brain structural changes in mood disorders”. Psychiatry3 (2009): 105-106.
    13. Roiser JP., et al. “Neuropsychology of affective disorders”. Psychiatry3 (2009): 91-96.
    14. Frangou S. “Functional neuroimaging in mood disorder”. Psychiatry 3 (2008): 102-104.
    15. Desmyter S., et al. “The role of neuroimaging in our understanding of the suicidal brain”. CNS and Neurological Disorders-Drug Targets 7 (2013): 921-929.
    16. Lu DY., et al. “Genetics in suicide treatments, modern diagnosis establishments”. Journal of Mental Disorders and Treatment 2 (2017): 145.
    17. Kendell R. “Diagnosis and classification of mood disorders”. Psychiatry 4 (2006): 112-114.
    18. Lu DY., et al. “Genetics and bioinformatics studies of antidepressant drug therapeutic efficacies and toxicities, a current overview”. Recent Patents on CNS Drug Discovery 3 (2014): 193-199.
    19. McAllister-Williams R and Ferrier IN. “Pharmacological management of unipolar affective disorder”. Psychiatry4 (2009): 113-119.
    20. McAllister-Williams R and Ferrier IN. “Pharmacological management of bipolar affective disorder”. Psychiatry6 (2009): 120-124.
    21. Lucas G. “Fast-acting antidepressants: are we nearly there”. Expert Review of Neurotherapeutics 1 (2000): 1-3.
    22. Menchetti M., et al. “Depression in primary care: Interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS study. A multicenter randomized controlled trial”. Rationale and design. BMC Psychiatry 10 (2010): 97.
    23. Menchetti M., et al. “Moderators of remission with interpersonal counseling or drug treatment in primary care patients with depression: randomized controlled trial”. British Journal of Psychiatry 2 (2014): 144-150.
    24. Malhotra D and Sebat J. “CNVs: harbingers of a rare variant revolution in psychiatric genetics”. Cell 148 (2012): 1223-1241.
    25. Krystal JH and State MW. “Psychiatric disorders: diagnosis to therapy”. Cell 157 (2014): 201-214.
    26. Desmyter S., et al. “The role of neuroimaging in our understanding of the suicidal brain”. CNS and Neurological Disorders-Drug Targets7 (2013): 921-929.
    27. Lu DY., et al. “Human suicide risk and treatment study”. Central Nervous System Agents in Medicinal Chemistry 3 (2018): 206-212.
    28. Lu DY., et al. “Suicide risks and prevention, neuropathogenic study”. Edeweiss: Psychiatry1 (2020): 124.
    29. Eagles JM. “Light therapy and seasonal affective disorder”. Psychiatry4 (2009): 125-129.
    30. Cao S., et al. “Future directions in the field of suicide study”. EC Orthopaedics6 (2017): 206-208.
    31. Lu DY., et al. “Undesired neural side-effects of a drug, a chemical and genetic interrelated problem”. Central Nervous System Agents in Medicinal Chemistry 2 (2010): 108-112.
    32. Lu DY., et al. “Pathology and medication for human suicide”. Cell and Develop Biology1 (2019): 201.
    33. Lu DY., et al. “The suicidal risks and treatments, seek medications from multi-disciplinary”. Central Nervous System Agents in Medicinal Chemistry 3 (2016): 231-239.
Citation: Da-Yong Lu., et al. “An Overview of Suicide Study”. EC Paediatrics 10.3 (2021): 37-43.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 21, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to